Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.

He, Xin; Findling, James W; Auchus, Richard J

He, Xin; Findling, James W; Auchus, Richard J.

Afiliación

He X; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, MI, USA.
Findling JW; Department of Medicine, Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Auchus RJ; Endocrinology Center and Clinics, Medical College of Wisconsin, Milwaukee, WI, USA.

Pituitary ; 25(3): 393-403, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35471718

Asunto(s)

Insuficiencia Suprarrenal; Síndrome de Cushing; Insuficiencia Suprarrenal/diagnóstico; Síndrome de Cushing/diagnóstico; Glucocorticoides/uso terapéutico; Humanos; Hidrocortisona; Sistema Hipotálamo-Hipofisario; Sistema Hipófiso-Suprarrenal

Palabras clave

Adrenal insufficiency; Corticosteroid withdrawal syndrome; Cushing disease; Cushing syndrome; Glucocorticoid withdrawal syndrome; Steroid withdrawal syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuficiencia Suprarrenal / Síndrome de Cushing Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Pituitary Asunto de la revista: ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google